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1. Introduction 
In studies of the subunit structure of human cerulo- 
plasmin, polypeptide chains of molecular weight 
around 17,000 [l-3] and 59,000 [3] have been 
reported. Other investigators have confirmed the 
presence of subunits by gel electrophoresis, but not 
determined their molecular weight [4,5] . In contrast 
to these findings procine ceruloplasmin has been 
reported to contain only one polypeptide chain of 
molecular weight 80,000 [6]. As this situation, if 
correct, has far-reaching implications for the evolution 
of the ceruloplasmin molecule, a closer study of the 
polypeptide chains of the human protein was under- 
taken. The results were, however, different for differ- 
ent samples investigated, and therefore the possibility 
of fragmentation of the protein in course of its pre- 
paration was considered. Indeed, ceruloplasmin pre- 
pared directly from fresh blood in a three-step proce- 
dure did not contain any of the above components, 
but rather a single heavy polypeptide chain. Further- 
more, short time incubation of the so prepared cerulo- 
plasmin with trypsin produced fragments similar to 
the earlier observed subunits. These results and the 
new preparation scheme are reported below. 
2. Materials and methods 
2.1. Commercial samples of ceruloplasmin 
Ceruloplasmin prepared from Cohn fractions IV-a 
or III, as described by Bjorling [7] was obtained from 
AB Kabi, Stockholm. The protein was delivered and 
stored as a sterile filtered 5% solution in 0.3 M NaCl 
at 4”. It was further fractionated by gradient chroma- 
tography on hydroxyapatite [8]. 
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2.2. Preparation of ceruloplasmin from fresh serum 
The fresh ceruloplasmin was prepared in a three 
step procedure essentially as described by Broman and 
Kjellin [9]. The preparation was completed in about 
7 days. All operations except clot formation were 
performed at 4”. Ceruloplasmin was located by its 
absorption at 610 nm. Its purity was estimated from 
the A 6lON&2zSONll ratio, assuming this to be 0.045 
for the pure protein (the value for the protein puri- 
fied by this procedure). The buffers were always 
potassium phosphate pH 6.8 (FB), containing 0.02 M 
e-aminocaproic acid to inhibit plasminogen activation 
[lOI. 
Serum. Blood was withdrawn directly into glass 
centrifuge tubes, containing e-aminocaproic acid to 
get a final concentration of 0.02 M. After clot forma- 
tion (1 hr room temp.) the tubes were centrifuged 
and the serum collected. The serum was further run at 
44,000 g for 2 hr to flotate the lipids. This was essen- 
tial for obtaining a clear solution and avoiding pre- 
cipitation in the ensuing gel filtration. 
DEAE-chromatography .300-400 ml of defatted 
serum was diluted five-fold with buffers to final con- 
centrations 0.03 M FB, 0.1 M NaCl and passed through 
a column (3.2 X 7 .O cm) of DEAE-Sephadex (Phar- 
macia Fine Chemicals) equilibrated with the same 
buffer. A blue band developed on the column. The 
sample, followed by 500 ml of starting buffer, was 
eluted by a linear gradient of NaCl(O.1 M + 0.45 M, 
total volume 1600 ml) the other salts being unchanged. 
The flow rate was about 100 ml/hr. Fractions with 
A : Fr,, not less than 0.003 were pooled and concen- 
trated by ultrafiltration in Diaflo equipment (Amicon). 
20-25 ml of about 20% pure ceruloplasmin was ob- 
tained per 100 ml of defatted serum. 
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Fig. 1. Chromatography on a column (2.0 X 75 cm) of 
hydroxyapatite of a ceruloplasminenriched fraction obtained 
by. DEAE-chromatography of human serum. The fractions in- 
dicated by the horizontal bar were pooled and further purified. 
Hydroxyapatite chromatography. Hydroxyapatite 
was prepared as described by Tiselius et al. [ 1 l] . The 
sample was dialyzed against starting buffer (0.075 M 
FB) and applied on the column, which was developed 
by a linear potassium phosphate gradient (0.075 M + 
6.5 M constant pH 6.8, total volume 1000 ml) at a 
flow rate of 12 ml/hr (fig. 1). Forms I and II of the 
protein [ 121 were well separated. The purity of cerulo- 
plasmin was about 85% in the best fractions. 85% of 
the applied amount was recovered, but only the central 
part of the first peak (about 50% of the applied amount) 
was pooled. 
Sephadex G-200 chromatography. The sample, 
concentrated to 2.0 ml in a Diaflo apparatus, was 
applied to a column of Sephadex G-200 equilibrated 
with 0.1 M NaCl, 0.03 M FB and run at 6.0 ml/hr 
(fig. 2). Some high molecular weight impurities were 
removed and the best fractions in the ceruloplasmin 
peak had a A6ronm/~sonm ratio of 0.045. This 
material was completely pure as tested by polyacryl- 
amide gel gradient electrophoresis (fig. 3). The protein 
could be stored at -20’ for several months without 
any noticeable change. 
2.3. Analytical procedures 
Gel filtration in 6 Mguanidine HCl. Was carried out 
essentially as described by Fish et al. [ 131 on a column 
Fig. 2. Chromatography on a column (‘2.0 X 109 cm) of 
Sephadex G-200 of the concentrated fist ceruloplasmin peak 
in fig. 1. 
of Sepharose 6B (Pharmacia Fine Chemicals) in 6.0 M 
guanidine HCI, 0.1 M Tris HCl, pH 8.5. Guanidine 
HCl was prepared from guanidine carbonate (BDH) 
and recrystallized in ethanol. Samples were prepared 
by dissolving 5 mg of protein in 200 1.t1 of the above 
buffer and incubating under N, with 10 ~1 of fl-mer- 
captoethanol for 4 hr and 10 ~1 of acrylonitrile for 
another 2 hr. The reaction mixture was layered under 
the solvent onto the top of the column, which was run 
at 3 5 ml/hr. Molecular weights were determined from 
a calibration curve (fig. 4) oonstructed essentially as 
described by Hjerten [ 141 . 
Starch gel electrophoresis. Was run in horizontal 
trays [15] in 8 M urea, 0.05 M formic acid, 0.01 M 
NaOH, pH 3 .O [ 161. Samples were applied on filter 
papers inserted in slots in the gel. Electrophoresis was 
carried out at 3.5 V/cm for 20-22 hr at 20”. The gels 
were stained with 0.015% nigrosin in water:methanol: 
acetic acid 4:5: 1, v/v, for 6 hr. 
Polyaclylamide gel gradient electrophoresis. Was 
performed as described by Margolis and Kenrick [ 171 
in a 0.09 M. Tris-borate-EDTA buffer pH 8.28 [ 181 at 
100 V for 24 hr in a Gradipore equipment (Universal 
Scientific Ltd, London). The gel gradient was 4-26%. 
Gels were stained in 0.1% ArnidoBlack in 7% acetic 
acid. 
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Fig. 3. Electrophoresis in a polyacrylamide gel gradient. 
Samples II and c are human sera and samples b and d are 
and 75 ,cg, respectively, of the freshly prepared cerulopla 
November 1971 
Fig. 4. Blot of log 100 Kd-W-N 3 for ribonuclease, myoglobin, 
chymotrypsinogen, pepsin and bovine serum albumin in order 
of decreasing value for N. Kd = Ve- Vo/Vre- Vo where Ve, 
VO and Vre denote, respectively, the elution volumes of the 
protein, Blue dextran 2000 (Pharmacia Fine Chemicals) and 
excess reagent from the reduction and cyanoethylation reac- 
tion. N is the number of amino acids in the protein polypep- 
tide chain. 
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Fig. 5. Starch gel electrophoresis in 8 M urea at pH 3 of cemloplasmin preparations (non-reduced proteins). Samples u-c are three 
different Kabi preparations. Sample d is the fresh ceruloplasmin preparation. Samples e-f is the fresh ceruloplasmin preparation 
after digestion with trypsin for 10 and 90 min (digestion conditions: enzyme: substrate 1:lOO (w/w), 0.03 M Tris-HCl pH 8.0, 
0.01 M CaClz, room temp.). The runs were done on different occasions and are not exactly comparable. 
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3. Results 
3.1, Comparison between commercial samples of 
ceruloplasmin and ceruloplasmin prepared from 
fresh serum 
Starch gel electrophoresis of three different 
batches of Kabi ceruloplasmin are shown in fig. 5 
a-c. They all contain similar components, but their 
proportions differ considerably in the three samples. 
Heavier components are seen in two of them. The 
fresh ceruloplasmin preparation (fig. 5d) does not 
contain any of these peptides but only one slow main 
component and a weak band just in front of it. 
Gel filtration in 6 M guanidine HCl of three differ- 
ent reduced and cyanoethylated Kabi ceruloplasmin 
preparations are seen in fig. 6 a-c. Two smaller pep- 
tides (peak fractions 60 and 66) were present in all 
three samples, though their relative amounts varied. 
Their molecular weights, as measured from a calibra- 
tion curve (fig. 4) were 22,000 and 16,000. The 
heavier component in sample a (peak fraction 52), 
molecular weight 38,800, is absent in samples b and c, 
where peptide chains of molecular weight 58,100 
(peak fraction 46, sample b) and 55,000 (peak fraction 
47, sample c) are present. The fresh ceruloplasmin 
preparation (fig. 6d) does not contain any of the dis- . 
cussed components except for trace amounts of the 
16,000 molecular weight peptide. Instead a single 
polypeptide chain with an estimated molecular weight 
of 110,000 is present. 
3.2. Limited proteolytic digestion 
The fresh ceruloplasmin preparation was incubated 
with trypsin and analyzed by starch gel electrophoresis 
(fig. 5 e-f). Fragments similar to those present in the 
Kabi ceruloplasmin batches appeared within 10 min 
and the heavy polypeptide chain characteristic of 
fresh ceruloplasmin disappeared. In the non-reduced 
protein no other changes were seen in the first 90 min, 
while some changes were seen in gel electrophoresis of 
the reduced protein (not shown). 
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Fig. 6. Gel filtration on a column (1.5 X 85 cm) of Sepharose 
6B in 6 M guanidine HCI, 0.1 M Tris-HCl pH 8.5, of reduced 
and cyanoethylated ceruloplasmin preparations. Samples u-c 
are three different Kabi ceruloplasmin batches. Sample d.is 
the fresh ceruloplasmin preparation. 
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4. Discussion more active than the best of the previous preparations. 
The subunit strucure of human ceruloplasmin has 
been analyzed by starch gel electrophoresis in 8 M 
urea at pH 3 both in this laboratory and by others 
[l-5] but the outcome has differed considerably for 
different samples of the protein. As incomplete dis- 
sociation may occur in the conditions used, 6 M 
guanidine HCl, where most proteins are random coils 
[ 191, was tried. By gel filtration in this medium, three 
batches of ceruloplasmin was shown to still contain 
different polypeptides (fig. 6 a-c). These can then at 
least not all be true subunits of the protein. This is also 
indicated by the stoichiometry of the peptides, which 
not at all fit a simple molecular formula. An estimate 
of the stoichiometry is obtained by comparing peak 
areas in the chromatogram (fig. 6). For sample a 
molar absorptivities were determined from molecular 
weight and amino acid composition for the isolated 
and electrophoretically homogeneous components 
and the stoichiometry 1:3.3:4 was calculated. The 
peptide chains of molecular weight 16,600 and 58,000 
are probably the same as those reported by Simons 
and Bearn [3]. 
The ceruloplasmin polypeptide chain eluted very 
close to the void volume on the Sepharose column 
(fig. 6). The estimation of the molecular weight is 
thus uncertain. A more rigorous study of its molecular 
weight is presently undertaken. 
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